Early versus Late Fluconazole Prophylaxis in Autologous Hematopoietic Cell Transplantation.

Transplantation and Cellular Therapy
Mariana GuaranaSimone A Nouér

Abstract

Candidemia is a major complication in hematopoietic cell transplantation (HCT), and antifungal prophylaxis with fluconazole decreases the incidence of this complication. We compared 2 strategies for fluconazole prophylaxis in patients with hematologic malignancy undergoing autologous HCT between 1997 and 2017. From 1997 to 2003, fluconazole prophylaxis (400 mg/d) was given to all HCTs, started with the conditioning regimen (early prophylaxis), and given until neutrophil engraftment or the need of non-prophylactic antifungal therapy. From 2004 on, fluconazole (400mg daily) was started only if (and when) the patient developed oral mucositis (late prophylaxis). Among 571 HCT, 270 received early prophylaxis, 112 received late prophylaxis, and 189 did not receive fluconazole because they did not develop oral mucositis. The incidence of candidemia was 1.8% in the early prophylaxis group, 0% in the late prophylaxis group, and 1.1% in the no prophylaxis group (P = .31). Among patients receiving fluconazole, the median duration of prophylaxis was 17 days (range, 6-36 days) in the early prophylaxis group and 6 days (range, 2-16 days) in the late prophylaxis group (P < .001). The initiation of fluconazole prophylaxis guided by the occurre...Continue Reading

References

Jun 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D Abi-SaidS Vartivarian
Aug 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C ViscoliF Meunier
Jan 29, 2000·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·L A BellmH J Fuchs
Apr 12, 2000·International Journal of Radiation Oncology, Biology, Physics·A TrottiW Curran
Nov 10, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M Nucci, E Anaissie
Jan 23, 2002·Bone Marrow Transplantation·A A ToorD J Weisdorf
May 17, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marcio NucciThomas F Patterson
Apr 2, 2004·Nature Reviews. Cancer·Stephen T Sonis
Jun 8, 2004·Seminars in Oncology·Douglas E Peterson, Anna Cariello
Jul 27, 2004·Bone Marrow Transplantation·E H WangE Carrier
Feb 14, 2007·Haematologica·Pasquale NiscolaPaolo de Fabritiis
Oct 6, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L PaganoF Aversa
Feb 13, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nicole BlijlevensUNKNOWN European Blood and Marrow Transplantation Mucositis Advisory Group
Oct 29, 2009·Bone Marrow Transplantation·K A MarrUNKNOWN Centers for Disease Control and Prevention
Mar 12, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dimitrios P KontoyiannisPeter G Pappas
Sep 27, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M NucciA L Colombo
Apr 22, 2019·Infectious Disease Clinics of North America·Derek J Bays, George R Thompson
Sep 23, 2020·Clinical Lymphoma, Myeloma & Leukemia·Mauricette MichalletRaoul Herbrecht
Nov 4, 2020·Mycoses·Luciana SouzaMarcio Nucci

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

© 2021 Meta ULC. All rights reserved